Nicholas Flytzanis
Fondateur chez Capsida Biotherapeutics, Inc.
Profil
Nicholas Flytzanis is the founder of Capsida Biotherapeutics, Inc. He has an undergraduate degree from the Massachusetts Institute of Technology and a doctorate degree from the California Institute of Technology.
Postes actifs de Nicholas Flytzanis
| Sociétés | Poste | Début |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Fondateur | - |
Formation de Nicholas Flytzanis
| Massachusetts Institute of Technology | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |